Kozakowski Nicolas, Soleiman Afschin, Pammer Johannes
Institute of Clinical Pathology, Medical University of Vienna, Währinger Gürtel 18-20, 1097 Vienna, Austria.
Pathol Oncol Res. 2008 Mar;14(1):9-13. doi: 10.1007/s12253-008-9006-3. Epub 2008 Mar 15.
BMI-1 regulates cell proliferation and differentiation, is involved in stem cell maintenance and can act as an oncogene. We investigated BMI-1 expression in healthy normal kidney and in 77 renal tumours by immunohistochemistry, and correlated it with tumour differentiation. BMI-1 could regularly be demonstrated in distal tubules and in Bowman's capsule, whereas it was mostly lacking in proximal tubules, indicating that it may rather be a differentiation marker of different renal cell populations than a stem cell marker. In contrast to previous studies demonstrating a correlation between BMI-1 expression and malignancy, we showed that its expression was inversely correlated with the differentiation grade of clear cell carcinoma. Furthermore, despite their different biologies, BMI-1 was strongly expressed in both papillary carcinomas and oncocytomas. Thus, in renal clear cell carcinomas BMI-1 is rather a differentiation marker lost in carcinomas with high malignancy than an oncogene involved in tumour progression.
BMI-1调节细胞增殖和分化,参与干细胞维持,并可作为一种癌基因。我们通过免疫组织化学研究了BMI-1在健康正常肾脏和77例肾肿瘤中的表达,并将其与肿瘤分化相关联。BMI-1可在远端小管和鲍曼囊中经常被检测到,而在近端小管中大多缺乏,这表明它可能更多是不同肾细胞群体的分化标志物而非干细胞标志物。与先前显示BMI-1表达与恶性肿瘤之间存在相关性的研究相反,我们表明其表达与透明细胞癌的分化程度呈负相关。此外,尽管乳头状癌和嗜酸细胞瘤生物学特性不同,但BMI-1在两者中均强烈表达。因此,在肾透明细胞癌中,BMI-1更像是在高恶性肿瘤中丢失的分化标志物,而非参与肿瘤进展的癌基因。